Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Clinical Trial Tobacco Marijuana [NA]
Clinical trial update for a study on cannabis use disorder and tobacco use disorder; study completed with results posted.
-
FDA approval · 2019-01-02FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for the Nicotine Transdermal System from Dr. Reddys Laboratories Inc. under NDA 020076. The action r…
-
CLINICAL_TRIALS research · 2018-12-28Clinical Trial Update: Sex Differences, Hormones & Smoking Cessation [NA]
A completed clinical trial examining sex differences, hormones, and smoking cessation outcomes.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Electronic Decision Support Systems for Smokers With Severe Mental Illness [NA]
Clinical trial evaluating electronic decision support systems for smokers with severe mental illness has completed, with results posted in 2…
-
CLINICAL_TRIALS research · 2018-11-23Clinical Trial Update: Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers [NA]
A completed clinical trial evaluating HIT-enhanced tobacco treatment for hospitalized smokers with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers [Phase 2]
Phase 2 trial examining intermittent or continuous acetylsalicylic acid (aspirin) and gene expression in nasal tissue of current smokers; co…
-
FDA approval · 2018-08-10FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation [NA]
A completed study from University College Dublin evaluated whether a smartphone app enhances Acceptance and Commitment Therapy group treatme…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Text Messaging for Supporting Quit Attempts [NA]
Completed clinical trial evaluating text messaging to support quit attempts; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers [NA]
A completed clinical trial evaluated switching smokers to reduced-oxidant or reduced-nicotine cigarettes.
-
FDA approval · 2018-07-23FDA Approved: TOPCARE NICOTINE — Supplemental Application (Topco Associates LLC)
The FDA approved a supplemental application for TOPCARE NICOTINE (nicotine polacrilex) from Topco Associates LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Theta Burst TMS as a Tool to Change Smoking Behavior [EARLY_Phase 1]
Early-phase study evaluating theta burst transcranial magnetic stimulation as a method to modify smoking behavior has completed its Phase 1 …
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement [Phase 2, Phase 3]
A Phase 2/3 trial evaluating personalized transdermal nicotine replacement for tobacco use disorder reports on efficacy and neural correlate…
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: Nicotine Metabolism and Low Nicotine Cigarettes [NA]
A completed clinical trial update studying nicotine metabolism and low-nicotine cigarettes.
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Quit4hlth: Enhancing Tobacco and Cancer Control Through Framed Text Messages [NA]
A completed clinical trial evaluating framed text messages to promote tobacco cessation and cancer control.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) [NA]
This document reports the completed STEP UP trial, a smoking treatment and exercise program for underserved populations. Results were posted…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control
This clinical trial update notes the completion of a multi-modal study evaluating varenicline’s effects on dopaminergic reward processing an…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia [NA]
The clinical trial investigating the use of electronic cigarettes to promote smoking reduction among individuals with schizophrenia has comp…
-
FDA approval · 2018-06-27FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)
The FDA approved a supplemental application for Dr. Reddy's Laboratories' nicotine transdermal system (nicotine patch). This document announ…
-
FDA approval · 2018-06-26FDA Approved: NICOTINE SUGAR FREE — Original Application (CVS Pharmacy)
FDA approved Nicotine Sugar Free (nicotine polacrilex) under an original application by CVS Pharmacy for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers [NA]
Completed clinical trial comparing post-discharge strategies for hospitalized smokers; results posted in June 2018.
-
FDA approval · 2018-06-05FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrylex) from Haleon US Holdings LLC.
-
FDA approval · 2018-06-05FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM (nicotine polacrilex) from Lil Drug Store Products, Inc., authoriz…
-
FDA approval · 2018-06-05FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC, authorizing changes under an ex…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Electronic Cigarettes vs Combustible Cigarettes and Nicotine Gum [NA]
A completed clinical trial comparing nicotine plasma concentrations and subjective effects among three electronic cigarettes relative to com…